It has been suggested that HMGB1 functions as a potentially oncogenic protein to promote tumor progress [15, 27, 28], and its overexpression in cancer cells affects the anti-cancer T-cell response through activation of intracellular signaling [15, 29]. The gene discussed is HMGB1; the disease is cancer.